Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Operating Leases (2024 - 2025)

Basel Medical (BMGL) posted Operating Leases of $3.1 million for Q4 2025, up 37.89% sequentially from $2.3 million in Q2 2025.

Analysis

Basel Medical (BMGL) Operating Leases (2024 - 2025) Analysis & Trends

Basel Medical has reported Operating Leases for 2 years, with the latest figure at $3.1 million in Q4 2025.

  • Quarterly Operating Leases changed N/A year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, up 10627.21% from the prior year.
  • Operating Leases climbed to $3.1 million in Q4 2025 per BMGL's latest filing, from $2.3 million in the prior quarter.
  • Over five years, Operating Leases peaked at $3.1 million in Q4 2025 and troughed at $21434.7 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 89.47 Bn 88.46 Bn 15.19 Bn
2 Tenet Healthcare 22.09 Bn 19.92 Bn 4.45 Bn
3 Encompass Health 12.08 Bn 11.95 Bn 1.34 Bn
4 Davita 11.86 Bn 11.17 Bn 1.16 Bn
5 Universal Health Services 10.15 Bn 10.01 Bn 3.29 Bn
6 Ensign 9.93 Bn 9.61 Bn 306.24 Mn
7 Chemed 6.90 Bn 6.86 Bn 221.47 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.31 Bn 4.15 Bn 192.10 Mn
10 Basel Medical 7.33 Mn 6.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.13 Mn
Jun 30, 2025 2.27 Mn
Jun 30, 2024 21,434.69